Document:

Separation Agreement, dated July 29, 2010

 Exhibit 10.54 
 [VAXGEN, INC. LETTERHEAD] 
 July 29, 2010 

James P. Panek 
 [Address] 

Dear James: 
 This letter sets forth the
substance of the separation agreement (the “Agreement”) that VaxGen, Inc. (the “Company”) is offering to you to aid in your employment transition. 

1. Separation. Your last day of work with the Company and your employment termination date will be July 31, 2010 (the
“Separation Date”). 
 2. Accrued Salary And Vacation. On the Separation Date, the Company will
pay you all accrued salary and all accrued and unused vacation earned through the Separation Date, at the rates then in effect, subject to standard payroll deductions and withholdings. You are entitled to these payments by law. 

3. Severance Payment. If you sign this Agreement and allow it to become effective as specified in paragraph 15 below, the Company
will pay you, as severance, $193,050, less standard payroll deductions and withholdings. This amount will be paid to you in a single lump sum as soon as practicable following the Effective Date (as defined below), but in no event later than five
(5) business days following the Effective Date. 
 4. Transaction Bonus. In addition to the severance payment
described in paragraph 3 above, you have received from the Company a transaction bonus of $52,000, less standard payroll deductions and withholdings, relating to the consummation of the diaDexus Merger as contemplated by your employment agreement
with the Company. 
 5. Health Insurance. To the extent provided by the federal COBRA law or, if applicable, state
insurance laws, and by the Company’s current group health insurance policies, you will be eligible to continue your group health insurance benefits following the Separation Date. Later, you may be able to convert to an individual policy through
the provider of the Company’s health insurance, if you wish. You will be provided with a separate notice describing your rights and obligations under COBRA. If you are eligible for and timely elect continued coverage under COBRA, the Company,
as part of this Agreement, will pay your COBRA premiums for a period of twelve (12) months following the Effective Date (the “Twelve-Month Period”), provided that any such payments shall immediately cease if you
voluntarily enroll in the group health insurance plan of another employer. You agree to immediately notify the Company in writing of any such enrollment. If within the Twelve-Month Period you are no longer eligible for coverage under COBRA, and also
are not eligible for coverage under another employer’s plan, the Company will reimburse your monthly premiums for individual health insurance coverage (including the cost of coverage for your dependents previously covered under COBRA, if any),
up to a maximum reimbursement amount of $6,000 per month and subject to your timely submission of documentation of your monthly premium amounts, through the earlier of the end of the Twelve-Month Period or until you are eligible for coverage under
another employer’s health insurance plan. 

 James P. Panek 
 July 29, 2010 
  Page
 2
 of 5 
  

 6. Stock Options. All stock option grants or other equity awards held by you on
the Separation Date (if any) shall be subject to accelerated vesting such that all unvested shares will become fully vested and exercisable effective as of the Separation Date. Your right to exercise any vested shares, and all other rights and
obligations with respect to your stock options, will be as set forth in your stock option agreement, grant notice and applicable plan documents. 
 7. Other Compensation Or Benefits. You acknowledge that, except as expressly provided in this Agreement, you will not receive any additional compensation, severance, or benefits from the Company
after the Separation Date. 
 8. Expense Reimbursements. You agree that, within ten (10) days of the Separation
Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse you for these expenses
pursuant to its regular business practice. 
 9. Return Of Property. By the Separation Date, you agree to return to the
Company all documents (and all copies thereof) belonging to the Company and all other property belonging to the Company that you have in your possession, including, but not limited to, all files, notes, drawings, records, business plans and
forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit cards, entry cards, identification badges, and keys; and, any materials of any kind that contain or
embody any proprietary or confidential information of the Company (and all reproductions thereof). Your timely return of all such documents and other property is a condition precedent to your receipt of the benefits provided under this Agreement.

 10. Proprietary Information Obligations. You acknowledge your continuing obligations under your Proprietary
Information and Inventions Agreement. 
 11. Confidentiality. The provisions of this Agreement will be held in the
strictest confidence by you, and you will not publicize or disclose them in any manner whatsoever, provided, however, that you may disclose this Agreement: (a) in confidence to your immediate family members, attorneys, accountants,
auditors, tax preparers, and financial advisors; and (b) insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law. In particular, and without limitation, you agree not to disclose the terms of this
Agreement to any current or former consultant or employee of the Company. 
 12. Nondisparagement. You agree not to
disparage the Company, or its officers, directors, employees, shareholders, or agents, in any manner likely to be harmful to its or their businesses, business reputations, or personal reputations, provided that you will respond accurately and fully
to any question, inquiry or request for information when required by legal process. 

 James P. Panek 
 July 29, 2010 
  Page
 3
 of 5 
  

 13. No Admissions. You understand and agree that the promises and payments in
consideration of this Agreement shall not be construed to be an admission of any liability or obligation by the Company to you or to any other person, and that the Company makes no such admission. 

14. Release of Claims. In exchange for the consideration provided to you by this Agreement that you are not otherwise entitled to
receive, are in any way related to events, acts, conduct, or omissions occurring prior to or on the date that you sign this Agreement (collectively, the “Released Claims”). The Released Claims include, but are not limited to:
(a) all claims arising out of or in any way related to your employment with the Company, or the termination of that employment; (b) all claims related to your compensation or benefits from the Company including salary, bonuses,
commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (c) all claims for breach of contract, wrongful termination, and breach of the implied
covenant of good faith and fair dealing; (d) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (e) all federal, state, and local statutory claims, including claims
for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the Civil Rights Act of 1866, the Fair Labor Standards Act, the Employee Retirement Income Security
Act, the Family Medical Leave Act, the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”), the California Labor Code, the California Family
Rights Act, the California Occupational Safety and Health Act, Section 17200 of the California Business and Professions Code and the California Fair Employment and Housing Act (as amended). Notwithstanding the foregoing, the following are not
included in the Released Claims (the “Excluded Claims”): (a) any rights or claims for indemnification you may have pursuant to any written indemnification agreement with the Company to which you are a party, the charter,
bylaws, or operating agreements of the Company, or under applicable law; (b) any rights that are not waivable as a matter of law; or (c) any claims arising from the breach of this Agreement. You hereby represent and warrant that, other
than the Excluded Claims, you are not aware of any claims you have or might have against any of the Released Parties that are not included in the Released Claims. 
 15. ADEA Waiver. You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA (“ADEA Waiver”). You also acknowledge
that the consideration given for the ADEA Waiver is in addition to anything of value to which you were already entitled. You are advised by this writing, as required by the ADEA, that: (a) your waiver and release do not apply to any claims that
may arise after you sign this Agreement; (b) you should consult with an attorney prior to executing this release; (c) you have twenty-one (21) days within which to consider this release (although you may choose to voluntarily execute
this release earlier); (d) you have seven (7) days following the execution of this release to revoke this Agreement (in a written revocation sent to me); and (e) this Agreement will not be effective until the eighth day after you sign
this Agreement, provided that you have not earlier revoked this Agreement (the “Effective Date”). You will not be entitled to receive any of the benefits specified by this Agreement unless and until it becomes effective.

 James P. Panek 
 July 29, 2010 
  Page
 4
 of 5 
  

 16. Section 1542 Waiver. In granting the release herein, which includes
claims that may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code: “A general release does not extend to claims that the creditor does not know or suspect to exist
in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.” You hereby expressly waive and relinquish all rights and benefits under that
section and any law or legal principle of similar effect in any jurisdiction with respect to the releases granted herein, including but not limited to the release of unknown and unsuspected claims granted in this Agreement. 

17. Miscellaneous. This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and
the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or
representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and
the Company, and inure to the benefit of both you and the Company, and your and its heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not
affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of
the State of California as applied to contracts made and to be performed entirely within California. Any ambiguity in this Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in
writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and facsimile signatures will suffice as original signatures. 

[Remainder of page intentionally left blank] 

 James P. Panek 
 July 29, 2010 
  Page
 5
 of 5 
  

 If this Agreement is acceptable to you, please sign below and return the original to me. 

We wish you the best in your future endeavors. 

Sincerely, 
  

			
	VaxGen, Inc.
		
	By:	 	   /s/ David J. Foster

		 	       David J. Foster
		 	       Executive Vice President, Chief Financial Officer and Secretary

I have read, understand and agree fully to the foregoing Agreement: 

 

			
	   /s/ James P. Panek

	JAMES P. PANEK
		
	Date:	 	   7/29/10Employment Agreement

 Exhibit 10.55 
 EMPLOYMENT AGREEMENT 
 This Agreement is made by and between diaDexus, Inc.
(the “Company”), and Emilia Zychlinsky Bulaevsky (“Executive”) effective as of January 10, 2011 (the “Effective Date”). 
 1. Duties and Scope of Employment. 
 (a) Positions; Employment Term;
Duties. Executive shall commence employment with the Company on January 10, 2011 (the date the Executive commences employment, the “Employment Commencement Date”) as the Executive Vice President of Product Development &
RA/QA – Chief Technical Officer. The Executive shall be an executive officer of the Company. The period of Executive’s employment hereunder is referred to herein as the Employment Term. During the Employment Term, Executive shall render
such business and professional services in the performance of her duties, consistent with Executive’s positions within the Company, as shall reasonably be assigned to her by the Company’s Chief Executive Officer. Executive shall receive
focal performance reviews periodically. 
 (b) Obligations. During the Employment Term, Executive shall devote her full
business efforts and time to the Company. Executive agrees, during the Employment Term, not to actively engage in any other employment, occupation or consulting activity for any direct or indirect remuneration without the prior approval of the Board
of Directors (the “Board”); provided, however, that i) Executive may serve in any capacity with any civic, educational or charitable organization, or as a member of corporate Boards of Directors or committees thereof upon which Executive
currently serves, without the approval of the Board; provided, further that Executive may devote a reasonable amount of time to managing her family investments, ii) Executive can remain a consultant to Chrysalis Laboratories, Inc. in connection with
which Executive maintains an equity position, and iii) Executive can consult for Hitachi Chemical Diagnostics until June 30, 2011 as part of a transition plan. 
 2. Employee Benefits; Indemnification Agreement. During the Employment Term, except as otherwise provided herein, Executive shall be eligible to participate in the employee benefit plans maintained
by the Company that are applicable to other senior management to the full extent provided for under those plans. Executive shall be entitled to twenty (20) days of paid time off in accordance with the Company’s policies for senior
executives of the Company, as may be amended from time to time. For the purposes of this agreement, “paid time off” includes vacation, personal time off, sick leave, family illness, bereavement leave and religious holiday observances.

 3. At-Will Employment. Executive and the Company understand and acknowledge that Executive’s employment with the
Company constitutes at-will employment. Subject to the Company’s obligation to provide severance benefits as specified herein, Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written
notice to the other party, with or without good cause or for any or no cause, at the option either of the Company or Executive. 

  
 -1-

 4. Compensation. 

(a) Base Salary. While employed by the Company, the Company shall pay the Executive as compensation for her services a base salary
at the annualized rate of $275,000 (as may be adjusted from time to time, the “Base Salary”). Such Base Salary shall be paid periodically in accordance with normal Company payroll practices and subject to the applicable withholding.
Executive’s Base Salary shall be reviewed annually by the Chief Executive Officer, who will recommend any adjustments to the Compensation Committee of the Board of Directors (the “Compensation Committee”) for approval. 

(b) Performance Bonus. Executive shall be eligible to receive annual performance bonuses of up to 35% of Executive’s Base
Salary. Executive’s performance for purposes of determining her entitlement to performance bonuses shall be evaluated by the Chief Executive Officer based upon criteria specified by the Compensation Committee. The payment of any bonus under
this Section 4(b) shall be subject to Executive’s employment with the Company through the end of the relevant evaluation period. Executive’s annual bonus opportunity shall be reviewed annually by the Chief Executive Officer and
approved by the Compensation Committee. Any bonus payable under this Section 4(b) shall be paid on or prior to March 15 of the year following the year to which such bonus relates. 

(c) Equity Compensation. Subject to the approval of the Board, at the Board meeting following the Employment
Commencement Date, Executive shall be granted an option (the “Option”) to purchase 330,000 shares of the Company’s common stock with an exercise price equal to the fair market value of the Company’s common stock on the date of
grant as determined by the Board. The Option will be an “incentive stock option” within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), to the maximum extent permitted by law. The
Option shall vest and become exercisable with respect to twenty-five percent (25%) of the shares subject thereto on the first anniversary of the Employment Commencement Date and with respect to 1/48th of the shares subject thereto on each monthly anniversary thereafter
such that the Option shall be fully vested and exercisable on the fourth (4th) anniversary of the Employment Commencement Date, in each case, subject to Executive’s continuous service to the Company through the applicable vesting date. The Option will otherwise be
subject to the terms and conditions of the Company’s current equity incentive plan and a stock option agreement to be entered into between the Company and Executive. 
 (d) Severance. If Executive experiences a Covered Termination, then, subject to Executive executing and not revoking a standard form of release of claims with the Company in a form acceptable to
the Company within sixty (60) days following such termination, (i) Executive shall be entitled to receive an amount equal to six (6) months’ Base Salary, less applicable withholding, in accordance with the Company’s standard
payroll practices, (ii) the Company shall reimburse Executive for the group health, dental and vision plan continuation coverage premiums for Executive and, if relevant, her covered dependents under Title X of the Consolidated Budget
Reconciliation Act of 1985, as amended (“COBRA”) for the lesser of (A) six (6) months from the date of Executive’s termination of service, or (B) the date upon which Executive and her covered dependents are covered by
similar plans of Executive’s new employer, and (iii) in the event of Executive’s Covered Termination within twelve (12) months following a Change in Control (as defined below), then, effective immediately prior to such Covered
Termination, Executive’s options to purchase shares of the common stock of the Company shall become vested and exercisable and/or the restrictions applicable to unvested or restricted shares of the common stock of the Company held by Executive
shall lapse, in each case, with respect to that number of shares which would have become vested had Executive remained in continuous service with the Company for an additional six months following the date of Executive’s Covered Termination.

  
 -2-

 For the purposes of this Agreement, “Cause” means: 

(i) A material act of dishonesty made by Executive in connection with Executive’s responsibilities as a service provider;

 (ii) Executive’s conviction of, or plea of nolo contendere to, a felony; 

(iii) Executive’s gross misconduct in connection with the performance of her duties hereunder; or 

(iv) Executive’s material breach of her obligations under this Agreement; 
 provided, however, that with respect to clauses (iii) and (iv), such actions shall not constitute Cause if they are cured by Executive within thirty (30) days following delivery to Executive of
a written explanation specifying the basis for the Company’s beliefs with respect to such clauses. 
 For the purposes of
this Agreement, “Good Reason” shall mean: 
 (i) A material reduction in Executive’s Base Salary; 

(ii) A material reduction in Executive’s authority or duties; 

(iii) The requirement that Executive’s principal place of employment materially relocates more than thirty-five (35) miles
from its current location; or 
 (iv) The Company’s material breach of its obligations under this Agreement; 

provided, however, that any such condition shall not provide a basis for termination for Good Reason if it is cured by the Company within thirty
(30) days following delivery to the Company of a written explanation specifying the basis for the Executive’s beliefs with respect to such condition within ninety (90) days of its first occurrence or if Executive fails to resign
within thirty (30) days following the Company’s failure to cure. 

  
 -3-

 For the purposes of this Agreement, “Covered Termination” shall mean the
termination of Executive’s employment with the Company by the Company for other than Cause or by the Executive for Good Reason. 
 For the purposes of this Agreement, “Change in Control” means: 
 (i)
Any person (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the beneficial owner (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company
representing fifty percent (50%) or more of the total voting power represented by the Company’s then outstanding voting securities; 
 (ii) A change in the composition of the Board occurring within a two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. Incumbent Directors shall mean
directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the Incumbent Directors at the time of such
election or nomination (but shall not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company); 

(iii) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation
which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent
(50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or 

(iv) The consummation of the sale or disposition by the Company of all or substantially all of the Company’s assets. 

The Executive shall not be required to mitigate the value of any severance benefits contemplated by Section 4 of this Agreement, nor
shall any such benefits be reduced by any earnings or benefits that the Executive may receive from any other source. 

Notwithstanding any provision to the contrary in this Agreement, no amount deemed by the Company to be deferred compensation subject to
Section 409A of the Code shall be payable pursuant to Section 4 unless Executive’s termination of employment constitutes a “separation from service” with the Company within the meaning of Section 409A of the Code and
the Department of Treasury regulations and other guidance promulgated thereunder and any such amount to which Executive becomes entitled shall be paid on the sixtieth (60th) day following Executive’s Covered Termination. 

  
 -4-

 Notwithstanding anything in this Section 4 to the contrary, if the Executive is deemed
at the time of her separation from service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this
Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (a) the expiration of the
six-month period measured from the date of the Executive’s “separation from service” with the Company (as such term is defined in the Treasury Regulations issued under Section 409A of the Code) or (b) the date of
Executive’s death. Upon the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this paragraph shall be paid in a lump sum to the Executive, and any remaining payments due under the
Agreement shall be paid as otherwise provided herein. 
 For purposes of Section 409A of the Code (including, without
limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive the installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly,
each installment payment hereunder shall at all times be considered a separate and distinct payment. 
 5. Total Disability
of Executive. If Executive becomes permanently and totally disabled (as defined in accordance with Section 22(e)(3) of the Code or its successor provision) during the term of this Agreement, Executive’s service hereunder shall
automatically terminate and Executive shall be treated as having been terminated other than for Cause for purposes of Section 4 of this Agreement. 
 6. Death of Executive. If Executive dies during the term of this Agreement, Executive shall be treated as having been terminated other than for Cause for purposes of Section 4 of this
Agreement. 
 7. Assignment. This Agreement shall be binding upon and inure to the benefit of (a) the heirs,
beneficiaries, executors and legal representatives of Executive upon Executive’s death and (b) any successor of the Company. Any such successor of the Company shall be deemed substituted for the Company under the terms of this Agreement
for all purposes. As used herein, successor shall include any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise, directly or indirectly acquires all or substantially all of the assets or
business of the Company. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement shall be assignable or transferable except through a testamentary disposition or by the laws of descent and distribution
upon the death of Executive. Any attempted assignment, transfer, conveyance or other disposition (other than as aforesaid) of any interest in the rights of Executive to receive any form of compensation hereunder shall be null and void. 

8. Notices. All notices, requests, demands and other communications called for hereunder shall be in writing and shall be deemed
given if (i) delivered personally or by facsimile, (ii) one (1) day after being sent by Federal Express or a similar commercial overnight service, or (iii) three (3) days after being mailed by registered or certified mail,
return receipt requested, prepaid and addressed to the parties or their successors in interest at the following addresses, or at such other addresses as the parties may designate by written notice in the manner aforesaid: 

  
 -5-

 If to the Company: 

Attn: Chief Executive Officer 
 diaDexus, Inc. 
 343 Oyster Point Boulevard 

South San Francisco, CA 94080 
 If to Executive: 
 Emilia Zychlinsky Bulaevsky, Ph.D. 

Or at the last residential address known by the Company. 
 9. Severability. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force
and effect without said provision. 
 10. Proprietary Information Agreement Executive has entered into the Company’s
standard Employment, Confidential Information, Invention Assignment and Arbitration Agreement (the “Proprietary Information Agreement”) which is incorporated herein by this reference. 

11. Entire Agreement. This Agreement, together with the Proprietary Information Agreement, represents the entire agreement and
understanding between the Company and Executive concerning Executive’s employment relationship with the Company, and supersedes and replaces any and all prior agreements and understandings concerning Executive’s employment relationship
with the Company. 
 12. Non-Binding Mediation, Arbitration and Equitable Relief. 

(a) The parties agree to make a good faith attempt to resolve any dispute or claim arising out of or related to this Agreement through
negotiation. In the event that any dispute or claim arising out of or related to this Agreement is not settled by the parties hereto, the parties will attempt in good faith to resolve such dispute or claim by non-binding mediation in San Mateo
County, California to be conducted by one mediator belonging to the American Arbitration Association. The mediation shall be held within thirty (30) days of the request therefor. 

  
 -6-

 (b) Except as provided in Section 12(e) below, Executive and the Company agree that, to
the extent permitted by law, any dispute or controversy arising out of, relating to, or in connection with this Agreement, or the interpretation, validity, construction, performance, breach, or termination thereof which has not been resolved by
negotiation or mediation as set forth in Section 12(a) shall be finally settled by binding arbitration to be held in San Mateo County, California, in accordance with the National Rules for the Resolution of Employment Disputes then in effect of
the American Arbitration Association (the “Rules”). The arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator shall be confidential, final, conclusive and binding on the parties to
the arbitration. Judgment may be entered under a protective order on the arbitrator’s decision in any court having jurisdiction. 
 (c) The arbitrator shall apply California law to the merits of any dispute or claim, without reference to rules of conflict of law. The arbitration proceedings shall be governed by federal arbitration law
and by the Rules, without reference to state arbitration law. Executive hereby expressly consents to the personal jurisdiction of the state and federal courts located in California for any action or proceeding arising from or relating to this
Agreement and/or relating to any arbitration in which the parties are participants. 
 (d) Executive understands that nothing in
Section 12 modifies Executive’s at-will status. Either the Company or Executive can terminate the employment relationship at any time, with or without cause. 
 (e) EXECUTIVE HAS READ AND UNDERSTANDS THIS SECTION 12, WHICH DISCUSSES ARBITRATION. EXECUTIVE UNDERSTANDS THAT BY SIGNING THIS AGREEMENT, EXECUTIVE AGREES, TO THE EXTENT PERMITTED BY LAW, TO SUBMIT ANY
FUTURE CLAIMS ARISING OUT OF, RELATING TO, OR IN CONNECTION WITH THIS AGREEMENT, OR THE INTERPRETATION, VALIDITY, CONSTRUCTION, PERFORMANCE, BREACH, OR TERMINATION THEREOF TO BINDING ARBITRATION, AND THAT THIS ARBITRATION CLAUSE CONSTITUTES A WAIVER
OF EXECUTIVE’S RIGHT TO A JURY TRIAL AND RELATES TO THE RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF THE EMPLOYER/EXECUTIVE RELATIONSHIP, INCLUDING BUT NOT LIMITED TO, THE FOLLOWING CLAIMS: 

(i) ANY AND ALL CLAIMS FOR WRONGFUL DISCHARGE OF EMPLOYMENT; BREACH OF CONTRACT, BOTH EXPRESS AND IMPLIED; BREACH OF THE COVENANT OF
GOOD FAITH AND FAIR DEALING, BOTH EXPRESS AND IMPLIED; NEGLIGENT OR INTENTIONAL INFLICTION OF EMOTIONAL DISTRESS; NEGLIGENT OR INTENTIONAL MISREPRESENTATION; NEGLIGENT OR INTENTIONAL INTERFERENCE WITH CONTRACT OR PROSPECTIVE ECONOMIC ADVANTAGE; AND
DEFAMATION. 

  
 -7-

 (ii) ANY AND ALL CLAIMS FOR VIOLATION OF ANY FEDERAL STATE OR MUNICIPAL STATUTE, INCLUDING,
BUT NOT LIMITED TO, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, THE CIVIL RIGHTS ACT OF 1991, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE AMERICANS WITH DISABILITIES ACT OF 1990, THE FAIR LABOR STANDARDS ACT, THE CALIFORNIA FAIR EMPLOYMENT
AND HOUSING ACT, AND LABOR CODE SECTION 201, et seq; 
 (iii) ANY AND ALL CLAIMS ARISING OUT OF ANY OTHER LAWS AND
REGULATIONS RELATING TO EMPLOYMENT OR EMPLOYMENT DISCRIMINATION. 
 13. No Oral Modification, Cancellation or Discharge.
This Agreement may only be amended, canceled or discharged in writing signed by the parties hereto. 
 14. Withholding.
The Company shall be entitled to withhold, or cause to be withheld, from payment any amount of withholding taxes required by law with respect to payments made to Executive in connection with her employment hereunder. 

15. Governing Law. This Agreement shall be governed by the laws of the State of California, without regard to the conflict of law
provisions thereof. 
 16. Acknowledgment. Executive acknowledges that she has had the opportunity to discuss this matter
with and obtain advice from her private attorney, has had sufficient time to, and has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 

  
 -8-

 IN WITNESS WHEREOF, the undersigned have executed this Agreement: 

 

							
	   /s/ Patrick Plewman
	  		  	 1/20/2011

	By:	  	Patrick Plewman	  		  	Date
	Title:	  	President and Chief Executive Officer	  		  	
			
	     /s/ Emilia Zychlinsky Bulaevsky
	  		  	 1/21/2011

	Emilia Zychlinsky Bulaevsky, Ph.D.	  		  	Date

  
 -9-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]